Study Attribute | Value |
---|---|
CEBS Accession Number: | 002-02912-0002-0000-8 |
Chemical Name: | Titanium dioxide |
CASRN: | 13463-67-7 |
NTP Study Type: | Genetic Toxicology - Mammalian Cell Cytogenetics |
NTP Study ID: | 766516_CA |
Study Result: | Negative |
Activation | Trial | Trial Call |
---|---|---|
No Activation | 1 | Negative |
Induced Rat Liver S9 | 1_S9 | Questionable |
Induced Rat Liver S9 | 2_S9 | Negative |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 100 | 4 | 0.040 | 3.0 | 1 | 0.010 | 1.0 | 3 | 0.030 | 2.0 | 0 | 0.000 | 0.0 |
Medium | 0 | 100 | 5 | 0.050 | 3.0 | 0 | 0.000 | 0.0 | 2 | 0.020 | 2.0 | 2 | 0.020 | 2.0 | |
Test Chemical: | Titanium dioxide | 15 | 100 | 14 | 0.140 | 7.0 | 2 | 0.020 | 2.0 | 12 | 0.120 | 6.0 | 0 | 0.000 | 0.0 |
20 | 100 | 8 | 0.080 | 6.0 | 3 | 0.030 | 3.0 | 5 | 0.050 | 4.0 | 0 | 0.000 | 0.0 | ||
25 | 100 | 10 | 0.100 | 7.0 | 7 | 0.070 | 6.0 | 3 | 0.030 | 2.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Mitomycin-C | 0.5 | 100 | 35 | 0.350 | 23.0 | 7 | 0.070 | 7.0 | 24 | 0.240 | 17.0 | 4 | 0.040 | 4.0 |
Mitomycin-C | 1 | 25 | 16 | 0.640 | 44.0 | 7 | 0.280 | 24.0 | 9 | 0.360 | 28.0 | 0 | 0.000 | 0.0 | |
Trend: | 1.048 | 2.571 | -0.225 | ||||||||||||
Probability: | 0.147 | 0.005 | 0.589 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 100 | 9 | 0.090 | 6.0 | 1 | 0.010 | 1.0 | 8 | 0.080 | 6.0 | 0 | 0.000 | 0.0 |
Medium | 0 | 100 | 4 | 0.040 | 4.0 | 1 | 0.010 | 1.0 | 3 | 0.030 | 3.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | Titanium dioxide | 15 | 100 | 4 | 0.040 | 4.0 | 1 | 0.010 | 1.0 | 3 | 0.030 | 3.0 | 0 | 0.000 | 0.0 |
20 | 100 | 17 | 0.170 | 13.0 | 8 | 0.080 | 8.0 | 9 | 0.090 | 7.0 | 0 | 0.000 | 0.0 | ||
25 | 100 | 6 | 0.060 | 6.0 | 3 | 0.030 | 3.0 | 3 | 0.030 | 3.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Cyclophosphamide | 7.5 | 100 | 13 | 0.130 | 11.0 | 3 | 0.030 | 3.0 | 10 | 0.100 | 8.0 | 0 | 0.000 | 0.0 |
Cyclophosphamide | 37.5 | 25 | 23 | 0.920 | 48.0 | 6 | 0.240 | 24.0 | 6 | 0.240 | 24.0 | 11 | 0.440 | 8.0 | |
Trend: | 1.458 | 1.766 | 0.536 | ||||||||||||
Probability: | 0.072 | 0.039 | 0.296 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 100 | 2 | 0.020 | 2.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 |
Medium | 0 | 100 | 6 | 0.060 | 6.0 | 1 | 0.010 | 1.0 | 5 | 0.050 | 5.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | Titanium dioxide | 15 | 100 | 4 | 0.040 | 4.0 | 2 | 0.020 | 2.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 |
20 | 100 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | ||
25 | 100 | 5 | 0.050 | 5.0 | 2 | 0.020 | 2.0 | 3 | 0.030 | 3.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Cyclophosphamide | 7.5 | 100 | 29 | 0.290 | 20.0 | 10 | 0.100 | 6.0 | 19 | 0.190 | 16.0 | 0 | 0.000 | 0.0 |
Cyclophosphamide | 37.5 | 25 | 37 | 1.480 | 60.0 | 5 | 0.200 | 16.0 | 22 | 0.880 | 48.0 | 10 | 0.400 | 4.0 | |
Trend: | -0.609 | 0.136 | -0.808 | ||||||||||||
Probability: | 0.729 | 0.446 | 0.791 |